Plasma glucocorticogenic activity, race/ethnicity and alcohol intake among San Francisco Bay Area women.

by Phum Tachachartvanich, Sylvia S Sanchez, Scarlett L Gomez, Esther M John, Martyn T Smith, Laura Fejerman
Published 2020-01-01

Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer

by Christine Y. Yeh, Ravali Adusumilli, Majlinda Kullolli, Parag Mallick, Esther M. John, Sharon J. Pitteri
Published 2017-10-01

Estrogenic activity, race/ethnicity, and Indigenous American ancestry among San Francisco Bay Area women.

by Sylvia S Sanchez, Phum Tachachartvanich, Frank Z Stanczyk, Scarlett L Gomez, Esther M John, Martyn T Smith, Laura Fejerman
Published 2019-01-01

The Impact of the first COVID-19 shelter-in-place announcement on social distancing, difficulty in daily activities, and levels of concern in the San Francisco Bay Area: A cross-se...

by Holly Elser, Mathew V Kiang, Esther M John, Julia F Simard, Melissa Bondy, Lorene M Nelson, Wei-Ting Chen, Eleni Linos
Published 2021-01-01

Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.

by Lisa W Chu, Esther M John, Baiyu Yang, Allison W Kurian, Yasaman Zia, Kai Yu, Sue A Ingles, Frank Z Stanczyk, Ann W Hsing
Published 2018-01-01

SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.

by Andrew J Pellatt, Roger K Wolff, Esther M John, Gabriela Torres-Mejia, Lisa M Hines, Kathy B Baumgartner, Anna R Giuliano, Abbie Lundgreen, Martha L Slattery
Published 2013-01-01

Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry

by Marcelle M. Dougan, Yuqing Li, Lisa W. Chu, Robert W. Haile, Alice S. Whittemore, Summer S. Han, Steven C. Moore, Joshua N. Sampson, Irene L. Andrulis, Esther M. John, Ann W. Hsing
Published 2018-05-01

Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer

by Jennifer D. Brooks, Esther M. John, Lene Mellemkjær, Charles F. Lynch, Julia A. Knight, Kathleen E. Malone, Anne S. Reiner, Leslie Bernstein, Xiaolin Liang, Roy E. Shore, Marilyn Stovall, WECARE Study Collaborative Group, Jonine L. Bernstein
Published 2016-11-01

The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data.

by Gary K Chen, Robert C Millikan, Esther M John, Christine B Ambrosone, Leslie Bernstein, Wei Zheng, Jennifer J Hu, Stephen J Chanock, Regina G Ziegler, Elisa V Bandera, Brian E Henderson, Christopher A Haiman, Daniel O Stram
Published 2010-09-01

Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer

by Lauren C. Houghton, Julia A. Knight, Mary Jane De Souza, Mandy Goldberg, Melissa L. White, Karen O’Toole, Wendy K. Chung, Angela R. Bradbury, Mary B. Daly, Irene L. Andrulis, Esther M. John, Saundra S. Buys, Mary Beth Terry
Published 2018-04-01

The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study

by Julia A. Knight, Kristina M. Blackmore, Jing Fan, Kathleen E. Malone, Esther M. John, Charles F. Lynch, Celine M. Vachon, Leslie Bernstein, Jennifer D. Brooks, Anne S. Reiner, Xiaolin Liang, Meghan Woods, WECARE Study Collaborative Group, Jonine L. Bernstein
Published 2018-03-01

Pubertal development in girls by breast cancer family history: the LEGACY girls cohort

by Mary Beth Terry, Theresa H. M. Keegan, Lauren C. Houghton, Mandy Goldberg, Irene L. Andrulis, Mary B. Daly, Saundra S. Buys, Ying Wei, Alice S. Whittemore, Angeline Protacio, Angela R. Bradbury, Wendy K. Chung, Julia A. Knight, Esther M. John
Published 2017-06-01

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

by Jennifer D. Brooks, Elizabeth A. Comen, Anne S. Reiner, Irene Orlow, Siok F. Leong, Xiaolin Liang, Lene Mellemkjær, Julia A. Knight, Charles F. Lynch, Esther M. John, Leslie Bernstein, Meghan Woods, David R. Doody, The WECARE Study collaborative group, Kathleen E. Malone, Jonine L. Bernstein
Published 2018-12-01

RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study.

by Florence Le Calvez-Kelm, Javier Oliver, Francesca Damiola, Nathalie Forey, Nivonirina Robinot, Geoffroy Durand, Catherine Voegele, Maxime P Vallée, Graham Byrnes, Breast Cancer Family Registry, John L Hopper, Melissa C Southey, Irene L Andrulis, Esther M John, Sean V Tavtigian, Fabienne Lesueur
Published 2012-01-01

A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study

by Jennifer D. Brooks, John D. Boice, Jr., Roy E. Shore, Anne S. Reiner, Susan A. Smith, Leslie Bernstein, Julia A. Knight, Charles F. Lynch, Esther M. John, Kathleen E. Malone, Lene Mellemkjaer, Rikke Langballe, Xiaolin Liang, Meghan Woods, Marc Tischkowitz, Patrick Concannon, Daniel O. Stram, Jonine L. Bernstein
Published 2020-12-01

Admixture mapping of African-American women in the AMBER Consortium identifies new loci for breast cancer and estrogen-receptor subtypes

by Edward Antonio Ruiz-Narvaez, Lara Elaine Sucheston-Campbell, Jeannette T Bensen, Song Yao, Stephen Haddad, Christopher A Haiman, Elisa V Bandera, Esther M John, Leslie Bernstein, Jennifer J Hu, Regina G Ziegler, Sandra L Deming, Andrew F Olshan, Christine B Ambrosone, Julie R Palmer, Kathryn L Lunetta
Published 2016-09-01

ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.

by Anne-Laure Renault, Fabienne Lesueur, Yan Coulombe, Stéphane Gobeil, Penny Soucy, Yosr Hamdi, Sylvie Desjardins, Florence Le Calvez-Kelm, Maxime Vallée, Catherine Voegele, Breast Cancer Family Registry, John L Hopper, Irene L Andrulis, Melissa C Southey, Esther M John, Jean-Yves Masson, Sean V Tavtigian, Jacques Simard
Published 2016-01-01

Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population

by Anne S. Reiner, Charles F. Lynch, Julia S. Sisti, Esther M. John, Jennifer D. Brooks, Leslie Bernstein, Julia A. Knight, Li Hsu, Patrick Concannon, Lene Mellemkjær, Marc Tischkowitz, Robert W. Haile, Ronglai Shen, Kathleen E. Malone, Meghan Woods, Xiaolin Liang, Monica Morrow, Jonine L. Bernstein, on behalf of WECARE Study Collaborative Group
Published 2017-07-01

Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas

by Joshua Hoffman, Laura Fejerman, Donglei Hu, Scott Huntsman, Min Li, Esther M. John, Gabriela Torres-Mejia, Larry Kushi, Yuan Chun Ding, Jeffrey Weitzel, Susan L. Neuhausen, Paul Lott, COLUMBUS Consortium, Magdalena Echeverry, Luis Carvajal-Carmona, Esteban Burchard, Celeste Eng, Jirong Long, Wei Zheng, Olufunmilayo Olopade, Dezheng Huo, Christopher Haiman, Elad Ziv
Published 2019-01-01

Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)

by Nur Zeinomar, Julia A. Knight, Jeanine M. Genkinger, Kelly-Anne Phillips, Mary B. Daly, Roger L. Milne, Gillian S. Dite, Rebecca D. Kehm, Yuyan Liao, Melissa C. Southey, Wendy K. Chung, Graham G. Giles, Sue-Anne McLachlan, Michael L. Friedlander, Prue C. Weideman, Gord Glendon, Stephanie Nesci, kConFab Investigators, Irene L. Andrulis, Saundra S. Buys, Esther M. John, Robert J. MacInnis, John L. Hopper, Mary Beth Terry
Published 2019-11-01